West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc.（WST）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · WST · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
West Pharmaceutical Services, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
WST 季度内部人买卖趋势
WST 内幕交易卖出 · WST 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · WST CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
WST 高管卖出股份 · WST 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Option | 473.593 | — | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Other | 134.927 | $42K | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Option | 295.995 | — | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Other | 84.329 | $26K | Form 4 |
| May 4, 2026 | Pucci Paolo Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Michels Douglas A Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Lockhart Stephen H Director | Award | 791 | — | Form 4 |
| May 4, 2026 | LAI GOLDMAN MYLA Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Keller Deborah L Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Joseph Molly Director | Award | 791 | — | Form 4 |
| May 4, 2026 | HAUGEN JANET BRUTSCHEA Director | Award | 791 | — | Form 4 |
| May 4, 2026 | FRIEL ROBERT F Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Feehery William F Director | Award | 791 | — | Form 4 |
| May 4, 2026 | BUTHMAN MARK A Director | Award | 791 | — | Form 4 |
| Apr 27, 2026 | Favorite Annette F Sr. VP & Chief HR Officer | Option | 2,817 | $235K | Form 4 |
| Apr 27, 2026 | Favorite Annette F Sr. VP & Chief HR Officer | Sale | 2,817 | $860K | Form 4 |
| Apr 27, 2026 | Winters Chad VP, Chief Accounting Officer | Option | 896 | $155K | Form 4 |
| Apr 27, 2026 | Winters Chad VP, Chief Accounting Officer | Sale | 896 | $269K | Form 4 |
| Feb 20, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option | 383.382 | — | Form 4 |
| Feb 20, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Other | 129.545 | $31K | Form 4 |
| Feb 20, 2026 | Witherspoon Charles VP & Treasurer | Option | 60.22 | — | Form 4 |
| Feb 20, 2026 | Witherspoon Charles VP & Treasurer | Other | 22.069 | $5K | Form 4 |
| Feb 20, 2026 | Winters Chad VP, Chief Accounting Officer | Option | 89.328 | — | Form 4 |
| Feb 20, 2026 | Winters Chad VP, Chief Accounting Officer | Other | 30.184 | $7K | Form 4 |
| Feb 18, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option | 82.299 | — | Form 4 |
Campbell Shane Alden
SVP, Proprietary Segment
日期
May 12
股数
134.927
均价
$312.07
总金额
$42K
Campbell Shane Alden
SVP, Proprietary Segment
日期
May 12
股数
84.329
均价
$312.07
总金额
$26K
Favorite Annette F
Sr. VP & Chief HR Officer
日期
Apr 27
股数
2,817
均价
$83.47
总金额
$235K
Favorite Annette F
Sr. VP & Chief HR Officer
日期
Apr 27
股数
2,817
均价
$305.20
总金额
$860K
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
日期
Feb 20
股数
383.382
均价
—
总金额
—
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
日期
Feb 20
股数
129.545
均价
$241.12
总金额
$31K
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
日期
Feb 18
股数
82.299
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 WST 内幕交易
WST 内幕交易
West Pharmaceutical Services, Inc.（WST）内幕交易数据来源于公司内部人（包括Favorite Annette F (Sr. VP & Chief HR Officer), Winters Chad (VP, Chief Accounting Officer), Campbell Shane Alden (SVP, Proprietary Segment)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。WST内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看West Pharmaceutical Services, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
WST 内幕交易 · 5个问题West Pharmaceutical Services, Inc.（WST）的内部人包括高管和董事，如Favorite Annette F (Sr. VP & Chief HR Officer), Winters Chad (VP, Chief Accounting Officer), Campbell Shane Alden (SVP, Proprietary Segment)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026